Lydia Usha to Neoplasms, Glandular and Epithelial
This is a "connection" page, showing publications Lydia Usha has written about Neoplasms, Glandular and Epithelial.
Connection Strength
0.096
-
A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies. Gynecol Oncol. 2011 Jun 01; 121(3):455-61.
Score: 0.096